Add Company
Join Now

Gryphon Bio Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Gryphon Bio's estimated annual revenue is currently $1.6M per year.(i)
  • Gryphon Bio's estimated revenue per employee is $155,000

Employee Data

  • Gryphon Bio has 10 Employees.(i)
  • Gryphon Bio grew their employee count by 67% last year.

Gryphon Bio's People

NameTitleEmail/Phone
1
Chief Operating OfficerReveal Email/Phone
2
Research ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.4M70-8%$53MN/A
#2
$32.4M167-26%$110MN/A
#3
$0.9M60%N/AN/A
#4
$2.8M1813%N/AN/A
#5
$0.8M5-50%N/AN/A
#6
$0.8M100%N/AN/A
#7
$14M90-12%N/AN/A
#8
$0.4M33610%$236.7MN/A
#9
$4.8M62-74%$160MN/A
#10
$3.7M24-8%N/AN/A
Add Company

What Is Gryphon Bio?

Traumatic brain injury (TBI), multiple sclerosis (MS), post-traumatic epilepsy (PTE), Alzheimer's disease and related dementias (ADRD), chronic traumatic encephalopathy (CTE), and related indications are leading causes of death and disability. Gryphon Bio is a preclinical-stage therapeutic bioconjugate company created to harness our co-founders' discovery of novel therapeutic targets and temporal biomarkers in unexpected waves of brain molecules in the blood. Mission: To develop and market the 1st therapeutic bioconjugate to accelerate brain repair and improve cognition. Vision: To pioneer therapeutic bioconjugates to improve the lives of patients with neurological or neurodegenerative diseases.

keywords:N/A

N/A

Total Funding

10

Number of Employees

$1.6M

Revenue (est)

67%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M1011%N/A
#2
$0.9M10N/AN/A
#3
$0.9M10N/AN/A
#4
$1.4M10N/AN/A
#5
$0.9M10N/AN/A